This is a cost-plus-fixed-fee delivery order awarded to Southern Research Institute by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $404,140 contract is to conduct hit-to-lead progression studies on interventional agents for the identification of anti-HIV lead compounds under the agency's Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. The contract has no set-aside...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, which has a ceiling value of $516,234.16, is for the identification of anti-HIV therapeutics and topical microbicides. It falls under NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The $99,998.00 contract requires Southern Research to acquire and store chemical compound libraries, and conduct high-throughput screening to identify and characterize at least one agent that can block HIV...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, valued at $275,547.00, is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for providing preclinical services related to the development of HIV therapeutics and topical microbicides. The work to be performed under...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The $684,610.00 contract is for the identification of anti-HIV therapeutics and topical microbicides, which falls under NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. The contract has a...
This is a $749,989.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The contract is for a 500,000 compound screen to identify inhibitors of Gag processing, a key step in the life cycle of the HIV virus. This work supports NIAID's in vitro testing resource for HIV...